9/13 - 9/20 North America Healthcare Market Weekly Report
<Weekly Report>









<References>
[1]FDA advisers support booster dose of Pfizer vaccine in older or high-risk adults | Healthcare Dive
[2] https://news.google.com/covid19/map?hl=en-US&mid=%2Fm%2F02j71&gl=US&ceid=US%3Aen
https://www.worldometers.info/coronavirus/?utm_campaign=instagramcoach1?
[3]https://covid.cdc.gov/covid-data-tracker/#vaccinations.
[4] COVID-19 Vaccination Required for Immigration Medical Examinations | USCIS
[5]New data from Israel, Pfizer show potent effect from third coronavirus shot | Healthcare Dive
[6] U.S. to Lift Travel Ban on Vaccinated Visitors - The New York Times (nytimes.com)
[8]Takeda wins FDA approval for targeted lung cancer drug | BioPharma Dive
[9] Intermountain inks merger deal with SCL Health to create $11B system | Healthcare Dive
[10]Lilly's COVID-19 antibody cleared by FDA for post-exposure prevention | BioPharma Dive
[11] FDA Approves First Biosimilar to Treat Macular Degeneration Disease and Other Eye Conditions | FDA
[12]CVS To Hire 1,100 New Employees In Massachusetts Ahead Of Winter – CBS Boston (cbslocal.com)
[14] Pandemic special enrollment period led to record number of ACA enrollees | Healthcare Dive
[15]FTC warns app makers fall under breach notification rule | Healthcare Dive
[17] https://www.mohw.go.kr/eng/nw/nw0101vw.jsp?PAR_MENU_ID=1007&MENU_ID=100701&page=1&CONT_SEQ=367935